ADP-ribosylhydrolase 3 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "ADP-ribosylhydrolase 3" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

18^th place

17^th place

1,626^th place

1,007^th place

low place

low place

doi.org

Glowacki G, Braren R, Firner K, Nissen M, Kühl M, Reche P, et al. (July 2002). "The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse". Protein Science. 11 (7): 1657–70. doi:10.1110/ps.0200602. PMC 2373659. PMID 12070318.
Oka S, Kato J, Moss J (January 2006). "Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase". The Journal of Biological Chemistry. 281 (2): 705–13. doi:10.1074/jbc.M510290200. PMID 16278211.
Fontana P, Bonfiglio JJ, Palazzo L, Bartlett E, Matic I, Ahel I (June 2017). "Serine ADP-ribosylation reversal by the hydrolase ARH3". eLife. 6. doi:10.7554/eLife.28533. PMC 5552275. PMID 28650317.
Rack JG, Palazzo L, Ahel I (March 2020). "(ADP-ribosyl)hydrolases: structure, function, and biology". Genes & Development. 34 (5–6): 263–284. doi:10.1101/gad.334631.119. PMC 7050489. PMID 32029451.
Stevens LA, Kato J, Kasamatsu A, Oda H, Lee DY, Moss J (December 2019). "The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD⁺ Hydrolysis". ACS Chemical Biology. 14 (12): 2576–2584. doi:10.1021/acschembio.9b00429. PMC 8388552. PMID 31599159.
Ono T, Kasamatsu A, Oka S, Moss J (November 2006). "The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases". Proceedings of the National Academy of Sciences of the United States of America. 103 (45): 16687–91. Bibcode:2006PNAS..10316687O. doi:10.1073/pnas.0607911103. PMC 1636516. PMID 17075046.
Rack JG, Liu Q, Zorzini V, Voorneveld J, Ariza A, Honarmand Ebrahimi K, et al. (July 2021). "Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal". Nature Communications. 12 (1): 4581. Bibcode:2021NatCo..12.4581R. doi:10.1038/s41467-021-24723-3. PMC 8319183. PMID 34321462.
Ghosh SG, Becker K, Huang H, Dixon-Salazar T, Chai G, Salpietro V, et al. (September 2018). "Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome". American Journal of Human Genetics. 103 (3): 431–439. doi:10.1016/j.ajhg.2018.07.010. PMC 6128219. PMID 30100084.
Aryan H, Razmara E, Farhud D, Zarif-Yeganeh M, Zokaei S, Hassani SA, et al. (August 2020). "Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report". BMC Neurology. 20 (1): 291. doi:10.1186/s12883-020-01873-3. PMC 7397971. PMID 32746785.
Danhauser K, Alhaddad B, Makowski C, Piekutowska-Abramczuk D, Syrbe S, Gomez-Ospina N, et al. (November 2018). "Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy". American Journal of Human Genetics. 103 (5): 817–825. doi:10.1016/j.ajhg.2018.10.005. PMC 6218634. PMID 30401461.
Beijer D, Agnew T, Rack JG, Prokhorova E, Deconinck T, Ceulemans B, et al. (November 2021). "Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response". Life Science Alliance. 4 (11): e202101057. doi:10.26508/lsa.202101057. PMC 8424258. PMID 34479984.
Mishra B, Fatima S, Agarwal A, Radhakrishnan DM, Garg A, Srivastava AK (January 2021). "Dystonia and Myelopathy in a Case of Stress-Induced Childhood-Onset Neurodegeneration with Ataxia and Seizures (CONDSIAS)". Movement Disorders Clinical Practice. 8 (1): 156–158. doi:10.1002/mdc3.13125. PMC 7780941. PMID 33426173.
Hanzlikova H, Prokhorova E, Krejcikova K, Cihlarova Z, Kalasova I, Kubovciak J, et al. (July 2020). "Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair". Nature Communications. 11 (1): 3391. Bibcode:2020NatCo..11.3391H. doi:10.1038/s41467-020-17069-9. PMC 7341855. PMID 32636369.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000116863 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000042558 – Ensembl, May 2017

genenames.org

"Gene symbol report | HUGO Gene Nomenclature Committee".

harvard.edu

ui.adsabs.harvard.edu

Ono T, Kasamatsu A, Oka S, Moss J (November 2006). "The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases". Proceedings of the National Academy of Sciences of the United States of America. 103 (45): 16687–91. Bibcode:2006PNAS..10316687O. doi:10.1073/pnas.0607911103. PMC 1636516. PMID 17075046.
Rack JG, Liu Q, Zorzini V, Voorneveld J, Ariza A, Honarmand Ebrahimi K, et al. (July 2021). "Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal". Nature Communications. 12 (1): 4581. Bibcode:2021NatCo..12.4581R. doi:10.1038/s41467-021-24723-3. PMC 8319183. PMID 34321462.
Hanzlikova H, Prokhorova E, Krejcikova K, Cihlarova Z, Kalasova I, Kubovciak J, et al. (July 2020). "Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair". Nature Communications. 11 (1): 3391. Bibcode:2020NatCo..11.3391H. doi:10.1038/s41467-020-17069-9. PMC 7341855. PMID 32636369.

nih.gov

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Glowacki G, Braren R, Firner K, Nissen M, Kühl M, Reche P, et al. (July 2002). "The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse". Protein Science. 11 (7): 1657–70. doi:10.1110/ps.0200602. PMC 2373659. PMID 12070318.
"Entrez Gene: ADPRHL2 ADP-ribosylhydrolase like 2".
Fontana P, Bonfiglio JJ, Palazzo L, Bartlett E, Matic I, Ahel I (June 2017). "Serine ADP-ribosylation reversal by the hydrolase ARH3". eLife. 6. doi:10.7554/eLife.28533. PMC 5552275. PMID 28650317.
Rack JG, Palazzo L, Ahel I (March 2020). "(ADP-ribosyl)hydrolases: structure, function, and biology". Genes & Development. 34 (5–6): 263–284. doi:10.1101/gad.334631.119. PMC 7050489. PMID 32029451.
Stevens LA, Kato J, Kasamatsu A, Oda H, Lee DY, Moss J (December 2019). "The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD⁺ Hydrolysis". ACS Chemical Biology. 14 (12): 2576–2584. doi:10.1021/acschembio.9b00429. PMC 8388552. PMID 31599159.
Ono T, Kasamatsu A, Oka S, Moss J (November 2006). "The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases". Proceedings of the National Academy of Sciences of the United States of America. 103 (45): 16687–91. Bibcode:2006PNAS..10316687O. doi:10.1073/pnas.0607911103. PMC 1636516. PMID 17075046.
Rack JG, Liu Q, Zorzini V, Voorneveld J, Ariza A, Honarmand Ebrahimi K, et al. (July 2021). "Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal". Nature Communications. 12 (1): 4581. Bibcode:2021NatCo..12.4581R. doi:10.1038/s41467-021-24723-3. PMC 8319183. PMID 34321462.
Ghosh SG, Becker K, Huang H, Dixon-Salazar T, Chai G, Salpietro V, et al. (September 2018). "Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome". American Journal of Human Genetics. 103 (3): 431–439. doi:10.1016/j.ajhg.2018.07.010. PMC 6128219. PMID 30100084.
Aryan H, Razmara E, Farhud D, Zarif-Yeganeh M, Zokaei S, Hassani SA, et al. (August 2020). "Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report". BMC Neurology. 20 (1): 291. doi:10.1186/s12883-020-01873-3. PMC 7397971. PMID 32746785.
Danhauser K, Alhaddad B, Makowski C, Piekutowska-Abramczuk D, Syrbe S, Gomez-Ospina N, et al. (November 2018). "Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy". American Journal of Human Genetics. 103 (5): 817–825. doi:10.1016/j.ajhg.2018.10.005. PMC 6218634. PMID 30401461.
Beijer D, Agnew T, Rack JG, Prokhorova E, Deconinck T, Ceulemans B, et al. (November 2021). "Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response". Life Science Alliance. 4 (11): e202101057. doi:10.26508/lsa.202101057. PMC 8424258. PMID 34479984.
Mishra B, Fatima S, Agarwal A, Radhakrishnan DM, Garg A, Srivastava AK (January 2021). "Dystonia and Myelopathy in a Case of Stress-Induced Childhood-Onset Neurodegeneration with Ataxia and Seizures (CONDSIAS)". Movement Disorders Clinical Practice. 8 (1): 156–158. doi:10.1002/mdc3.13125. PMC 7780941. PMID 33426173.
Hanzlikova H, Prokhorova E, Krejcikova K, Cihlarova Z, Kalasova I, Kubovciak J, et al. (July 2020). "Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair". Nature Communications. 11 (1): 3391. Bibcode:2020NatCo..11.3391H. doi:10.1038/s41467-020-17069-9. PMC 7341855. PMID 32636369.

pubmed.ncbi.nlm.nih.gov

Glowacki G, Braren R, Firner K, Nissen M, Kühl M, Reche P, et al. (July 2002). "The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse". Protein Science. 11 (7): 1657–70. doi:10.1110/ps.0200602. PMC 2373659. PMID 12070318.
Oka S, Kato J, Moss J (January 2006). "Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase". The Journal of Biological Chemistry. 281 (2): 705–13. doi:10.1074/jbc.M510290200. PMID 16278211.
Fontana P, Bonfiglio JJ, Palazzo L, Bartlett E, Matic I, Ahel I (June 2017). "Serine ADP-ribosylation reversal by the hydrolase ARH3". eLife. 6. doi:10.7554/eLife.28533. PMC 5552275. PMID 28650317.
Rack JG, Palazzo L, Ahel I (March 2020). "(ADP-ribosyl)hydrolases: structure, function, and biology". Genes & Development. 34 (5–6): 263–284. doi:10.1101/gad.334631.119. PMC 7050489. PMID 32029451.
Stevens LA, Kato J, Kasamatsu A, Oda H, Lee DY, Moss J (December 2019). "The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD⁺ Hydrolysis". ACS Chemical Biology. 14 (12): 2576–2584. doi:10.1021/acschembio.9b00429. PMC 8388552. PMID 31599159.
Ono T, Kasamatsu A, Oka S, Moss J (November 2006). "The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases". Proceedings of the National Academy of Sciences of the United States of America. 103 (45): 16687–91. Bibcode:2006PNAS..10316687O. doi:10.1073/pnas.0607911103. PMC 1636516. PMID 17075046.
Rack JG, Liu Q, Zorzini V, Voorneveld J, Ariza A, Honarmand Ebrahimi K, et al. (July 2021). "Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal". Nature Communications. 12 (1): 4581. Bibcode:2021NatCo..12.4581R. doi:10.1038/s41467-021-24723-3. PMC 8319183. PMID 34321462.
Ghosh SG, Becker K, Huang H, Dixon-Salazar T, Chai G, Salpietro V, et al. (September 2018). "Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome". American Journal of Human Genetics. 103 (3): 431–439. doi:10.1016/j.ajhg.2018.07.010. PMC 6128219. PMID 30100084.
Aryan H, Razmara E, Farhud D, Zarif-Yeganeh M, Zokaei S, Hassani SA, et al. (August 2020). "Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report". BMC Neurology. 20 (1): 291. doi:10.1186/s12883-020-01873-3. PMC 7397971. PMID 32746785.
Danhauser K, Alhaddad B, Makowski C, Piekutowska-Abramczuk D, Syrbe S, Gomez-Ospina N, et al. (November 2018). "Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy". American Journal of Human Genetics. 103 (5): 817–825. doi:10.1016/j.ajhg.2018.10.005. PMC 6218634. PMID 30401461.
Beijer D, Agnew T, Rack JG, Prokhorova E, Deconinck T, Ceulemans B, et al. (November 2021). "Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response". Life Science Alliance. 4 (11): e202101057. doi:10.26508/lsa.202101057. PMC 8424258. PMID 34479984.
Mishra B, Fatima S, Agarwal A, Radhakrishnan DM, Garg A, Srivastava AK (January 2021). "Dystonia and Myelopathy in a Case of Stress-Induced Childhood-Onset Neurodegeneration with Ataxia and Seizures (CONDSIAS)". Movement Disorders Clinical Practice. 8 (1): 156–158. doi:10.1002/mdc3.13125. PMC 7780941. PMID 33426173.
Hanzlikova H, Prokhorova E, Krejcikova K, Cihlarova Z, Kalasova I, Kubovciak J, et al. (July 2020). "Pathogenic ARH3 mutations result in ADP-ribose chromatin scars during DNA strand break repair". Nature Communications. 11 (1): 3391. Bibcode:2020NatCo..11.3391H. doi:10.1038/s41467-020-17069-9. PMC 7341855. PMID 32636369.